Intervention 1: Intervention group: Alpha-lipoic acid supplements (Support Nutrition Pharmaceutical Company, USA), 600 mg, daily, for 12 weeks orally. Intervention 2: Control group: Placebo (Barij Ess

2 trials

Sponsors

Kashan University of Medical Sciences, National Institute for Medical Research Development of Iran (NIMAD)

Conditions

Coronary Heart Disease. Chronic ischemic heart disease, unspecified

Phase 3

Alpha-lipoic acid effects on coronary heart disease

Active, not recruitingIRCT20170513033941N48

Kashan University of Medical SciencesCoronary Heart Disease. Chronic ischemic heart disease, unspecified

Start: 2019-01-22Target: 60Updated: 2019-02-25

The effects of alpha-lipoic acid supplementation in patients with coronary heart disease

Active, not recruitingIRCT20170513033941N49

National Institute for Medical Research Development of Iran (NIMAD)Coronary Heart Disease. Chronic ischemic heart disease, unspecified

Start: 2019-01-22Target: 60Updated: 2019-05-21